TY - JOUR
T1 - Trust in Black and White Breast Cancer Patients
T2 - Opportunities to Enhance Trustworthiness in Cancer Care
AU - Sheppard, Vanessa B.
AU - Tariq, Fariha
AU - Bastiach, Dustin
AU - Philips, Malik
AU - Winn, Robert
AU - Edmonds, Megan C.
AU - Thompson, Hayley S.
N1 - Publisher Copyright:
© 2024 Elsevier Inc.
PY - 2024/12
Y1 - 2024/12
N2 - Introduction: This study evaluated the relationships between patient and cancer delivery factors with trust in oncology providers in a racial/ethnically diverse group of cancer patients. Methods: Data were analyzed from a prospective cohort study of women with hormone receptor positive (HR+) breast cancer. A standardized survey collected validated measures of trust in providers, psychosocial factors, and cancer care delivery factors. Multivariable logistic regression models and race-stratified models were employed to calculate odds ratios and 95% confidence intervals associated with trust. Results: Of the 567 participants, 28% identified as Black and the rest were White. Compared to White women Black women reported lower trust in providers. Four domains of cancer care delivery were significantly associated with patients’ higher trust in their providers: general satisfaction with care (P <.0001), technical quality of the provider (P <.001), interpersonal manner of the provider (P =.0008) and provider communication (P =.0010). Race-stratified models revealed 2 significant cancer care delivery domains for both groups (ie, general satisfaction and interpersonal) and 2 care domains (technical quality and communication) that were only significant among White women. Conclusion: Efforts are needed to nurture trusting relationships between Black women and their oncology providers. Factors related to the organization and delivery of cancer care are modifiable targets for interventions as these were robust predictors of patient trust regardless of a woman's self-reported race. Investments in strategies that strengthen the structure and organization of care towards a structures of trust worthiness may better support providers and patients and ultimately reduce cancer care disparities.
AB - Introduction: This study evaluated the relationships between patient and cancer delivery factors with trust in oncology providers in a racial/ethnically diverse group of cancer patients. Methods: Data were analyzed from a prospective cohort study of women with hormone receptor positive (HR+) breast cancer. A standardized survey collected validated measures of trust in providers, psychosocial factors, and cancer care delivery factors. Multivariable logistic regression models and race-stratified models were employed to calculate odds ratios and 95% confidence intervals associated with trust. Results: Of the 567 participants, 28% identified as Black and the rest were White. Compared to White women Black women reported lower trust in providers. Four domains of cancer care delivery were significantly associated with patients’ higher trust in their providers: general satisfaction with care (P <.0001), technical quality of the provider (P <.001), interpersonal manner of the provider (P =.0008) and provider communication (P =.0010). Race-stratified models revealed 2 significant cancer care delivery domains for both groups (ie, general satisfaction and interpersonal) and 2 care domains (technical quality and communication) that were only significant among White women. Conclusion: Efforts are needed to nurture trusting relationships between Black women and their oncology providers. Factors related to the organization and delivery of cancer care are modifiable targets for interventions as these were robust predictors of patient trust regardless of a woman's self-reported race. Investments in strategies that strengthen the structure and organization of care towards a structures of trust worthiness may better support providers and patients and ultimately reduce cancer care disparities.
KW - African American
KW - Cancer care delivery
KW - Disparities
KW - Patient provider relationship
KW - Survivorship
UR - http://www.scopus.com/inward/record.url?scp=85204461477&partnerID=8YFLogxK
U2 - 10.1016/j.clbc.2024.08.019
DO - 10.1016/j.clbc.2024.08.019
M3 - Article
AN - SCOPUS:85204461477
SN - 1526-8209
VL - 24
SP - e748-e756
JO - Clinical Breast Cancer
JF - Clinical Breast Cancer
IS - 8
ER -